Jozien Helleman
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 6
- MicroRNA in disease regulation 4
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 6
- Oncology top 5%
- Molecular Biology top 10%
- Circular RNAs in diseases 3
-
- Prostate Cancer Diagnosis and Treatment 18
- Prostate Cancer Treatment and Research 17
- Renal cell carcinoma treatment 3
-
- Cancer Mechanisms and Therapy 3
- Co-authors
- Els M.J.J. BernsErik A.C. WiemerMaurice P.H.M. JansenMarijn T. M. van JaarsveldWilfred F. J. van IJckenE. BernsKirsten Ruigrok-RitstierMarcel Smid
- Partner nations
- NetherlandsBelgiumUnited Kingdom
In The Last Decade
Jozien Helleman
42 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 105
- Cancer Research 670
- Reproductive Medicine 303
- Oncology 566
- Molecular Biology 1.1k
- Pulmonary and Respiratory Medicine 457
Countries citing papers authored by Jozien Helleman
This map shows the geographic impact of Jozien Helleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jozien Helleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jozien Helleman more than expected).
Fields of papers citing papers by Jozien Helleman
This network shows the impact of papers produced by Jozien Helleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jozien Helleman. The network helps show where Jozien Helleman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jozien Helleman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 11 | |
| 2 | 2023 | 3 | |
| 3 | 2022 | 4 | |
| 4 | 2021 | 4 | |
| 5 | 2021 | 13 | |
| 6 | 2020 | 7 | |
| 7 | 2020 | 37 | |
| 8 | 2018 | 107 | |
| 9 | 2018 | 78 | |
| 10 | 2016 | 52 | |
| 11 | 2010 | 101 | |
| 12 | 2010 | 121 | |
| 13 | 2009 | 95 | |
| 14 | 2008 | 142 | |
| 15 | 2008 | 35 | |
| 16 | 2007 | 19 | |
| 17 | 2006 | 71 | |
| 18 | 2006 | 36 | |
| 19 | 2005 | 126 | |
| 20 | 2002 | 18 |
About Jozien Helleman
Jozien Helleman is a scholar working on Cancer Research, Reproductive Medicine and Pulmonary and Respiratory Medicine, having authored 42 papers that have together received 2.0k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (18 papers), Prostate Cancer Treatment and Research (17 papers), Ovarian cancer diagnosis and treatment (6 papers), Cancer Genomics and Diagnostics (6 papers), MicroRNA in disease regulation (4 papers), Renal cell carcinoma treatment (3 papers), Cancer Mechanisms and Therapy (3 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Cancer Research (670 citations), Reproductive Medicine (303 citations) and Oncology (566 citations). Jozien Helleman has collaborated with scholars based in Netherlands, Belgium and United Kingdom. Frequent co-authors include Els M.J.J. Berns, Erik A.C. Wiemer, Maurice P.H.M. Jansen, Marijn T. M. van Jaarsveld, Wilfred F. J. van IJcken, E. Berns, Kirsten Ruigrok-Ritstier, Marcel Smid, Ron H.J. Mathijssen and Iris L. van Staveren. Their work appears in journals such as PLoS ONE, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.